Publication | Open Access

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial

Treatment And PreventionDolutegravir Versus EfavirenzReproductive HealthAntiviral TherapyGynecologyMaternal HealthLate PregnancyHiv TherapyHivPublic HealthMedicineAntiviral DrugWomen's HealthHigh-risk Pregnancy